<div id="readability-page-1">05:28 PM EST, 02/09/2026 (MT Newswires) -- Agomab Therapeutics ( AGMB ) said late Monday it closed its initial public offering of 12.5 million American depository shares at a public offering price of $16 per ADS, raising about $200 million in gross proceeds before underwriting fees and expenses.The American depository shares started trading on the Nasdaq Global Select Market on Feb. 6. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

AGMB

东部时间 2026 年 2 月 9 日下午 5:28（MT Newswires）-- Agomab Therapeutics（AGMB）周一晚间表示，已完成 1250 万份美国存托股票的首次公开募股，公开发行价格为每份 ADS 16 美元，筹集了约 2 亿美元的总收入，未扣除承销费用和开支。这些美国存托股票于 2 月 6 日在纳斯达克全球精选市场开始交易。MT Newswires 不提供投资建议。未经授权的复制是严格禁止的

AgomAb Therapeutics 完成 2 亿美元首次公开募股